SCHEMBL25001809

SCHEMBL25001809

CN/C=C(\C=N)c1cc(Nc2ncc(Br)c(Nc3ccc4ncccc4c3P(C)(C)=O)n2)c(OC)cc1N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.52
▸ ULK1 O75385 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25001811 0.89 EGFR (0.54) EGFR
SCHEMBL25001841 0.88 EGFR (0.54) EGFR
SCHEMBL25002048 0.87 EGFR (0.67) EGFR
SCHEMBL23759759 0.86 EGFR (0.56) EGFR
SCHEMBL25002848 0.85 EGFR (0.54) EGFRULK1
SCHEMBL25002391 0.84 ULK1 (0.48) EGFRULK1
SCHEMBL25001753 0.84 EGFR (0.60) EGFR
SCHEMBL25002999 0.83 EGFR (0.68) EGFR
SCHEMBL25001825 0.83 EGFR (0.75) EGFR
SCHEMBL25001948 0.82 EGFR (0.64) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback